Open Access

Comparison of PICC and TIVAP in chemotherapy for patients with thyroid cancer

  • Authors:
    • Fangmei Qi
    • Hairong Cheng
    • Xiying Yuan
    • Li Zhang
  • View Affiliations

  • Published online on: June 15, 2020     https://doi.org/10.3892/ol.2020.11732
  • Pages: 1657-1662
  • Copyright: © Qi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Peripherally inserted central catheters (PICC) and totally implantable venous‑access ports (TIVAP) were compared in chemotherapy for patients with thyroid cancer. A retrospective analysis was performed on the clinical data of patients with thyroid cancer who were treated with PICC and TIVAP for chemotherapy in Qingdao Municipal Hospital from January 2013 to March 2018. Patients in the PICC and TIVAP groups were compared in terms of the success rate, indwelling time, complications, quality of life and nursing satisfaction. There was no statistically significant difference in the success rate between the two groups (P>0.05). The indwelling time in the TIVAP group was significantly longer than that in the PICC group (P<0.05). The incidence rate of complications in the TIVAP group (0%) was significantly lower than that in the PICC group (14.58%) (P<0.05). The quality of life score in the PICC group was significantly lower than that in the TIVAP group (P<0.05). There was no statistically significant difference in the nursing satisfaction score between the two groups (P>0.05). In conclusion, as an ideal venous access to chemotherapy for thyroid cancer, TIVAP has longer indwelling time and fewer adverse reactions and improves the quality of life of the patients.

Related Articles

Journal Cover

August-2020
Volume 20 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Qi F, Cheng H, Yuan X and Zhang L: Comparison of PICC and TIVAP in chemotherapy for patients with thyroid cancer. Oncol Lett 20: 1657-1662, 2020
APA
Qi, F., Cheng, H., Yuan, X., & Zhang, L. (2020). Comparison of PICC and TIVAP in chemotherapy for patients with thyroid cancer. Oncology Letters, 20, 1657-1662. https://doi.org/10.3892/ol.2020.11732
MLA
Qi, F., Cheng, H., Yuan, X., Zhang, L."Comparison of PICC and TIVAP in chemotherapy for patients with thyroid cancer". Oncology Letters 20.2 (2020): 1657-1662.
Chicago
Qi, F., Cheng, H., Yuan, X., Zhang, L."Comparison of PICC and TIVAP in chemotherapy for patients with thyroid cancer". Oncology Letters 20, no. 2 (2020): 1657-1662. https://doi.org/10.3892/ol.2020.11732